HuGE Literature Finder
Records
1
-
2
Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma. Frontiers in oncology 2022 1 11 664397. Chen Ying, Cui Xiaoying, Wang Di, Xia Guojie, Xing Minyan, Cheng Lei, Sheng Liming, Du Xiangh |
PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: